IDO Inhibitor Study for Relapsed or Refractory Solid Tumors

Summary

This study provides an early evaluation of an entirely new class of small molecule agents directed at disruption or elimination of tumor tolerance, a phenomenon now demonstrated to be involved in the growth of many solid tumors.

Timeline

Start

2008-08

Primary completion

2012-10

Completion

2012-10

Publications

• Ino K. Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer. Curr Opin Obstet Gynecol. 2011 Feb;23(1):13-8. doi: 10.1097/GCO.0b013e3283409c79.

Drugs

Indications